[go: up one dir, main page]

NO322200B1 - Forbedrede farmasoytiske preparater inneholdende ibuprofen og kodein og fremgangsmate for fremstilling derav - Google Patents

Forbedrede farmasoytiske preparater inneholdende ibuprofen og kodein og fremgangsmate for fremstilling derav Download PDF

Info

Publication number
NO322200B1
NO322200B1 NO19970782A NO970782A NO322200B1 NO 322200 B1 NO322200 B1 NO 322200B1 NO 19970782 A NO19970782 A NO 19970782A NO 970782 A NO970782 A NO 970782A NO 322200 B1 NO322200 B1 NO 322200B1
Authority
NO
Norway
Prior art keywords
preparation according
codeine
preparation
ibuprofen
mixtures
Prior art date
Application number
NO19970782A
Other languages
English (en)
Norwegian (no)
Other versions
NO970782L (no
NO970782D0 (no
Inventor
Brian Holmes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417041A external-priority patent/GB9417041D0/en
Priority claimed from GB9419921A external-priority patent/GB9419921D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO970782L publication Critical patent/NO970782L/no
Publication of NO970782D0 publication Critical patent/NO970782D0/no
Publication of NO322200B1 publication Critical patent/NO322200B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO19970782A 1994-08-23 1997-02-20 Forbedrede farmasoytiske preparater inneholdende ibuprofen og kodein og fremgangsmate for fremstilling derav NO322200B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417041A GB9417041D0 (en) 1994-08-23 1994-08-23 Improved formulations
GB9419921A GB9419921D0 (en) 1994-10-04 1994-10-04 Improved formulations
PCT/GB1995/001947 WO1996005834A1 (en) 1994-08-23 1995-08-16 Improved pharmaceutical formulations containing ibuprofen and codeine

Publications (3)

Publication Number Publication Date
NO970782L NO970782L (no) 1997-02-20
NO970782D0 NO970782D0 (no) 1997-02-20
NO322200B1 true NO322200B1 (no) 2006-08-28

Family

ID=26305507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970782A NO322200B1 (no) 1994-08-23 1997-02-20 Forbedrede farmasoytiske preparater inneholdende ibuprofen og kodein og fremgangsmate for fremstilling derav

Country Status (24)

Country Link
EP (1) EP0777477B1 (pt)
JP (1) JP3874793B2 (pt)
KR (1) KR100397082B1 (pt)
CN (1) CN1083265C (pt)
AT (1) ATE227574T1 (pt)
AU (1) AU699224B2 (pt)
BG (1) BG63329B1 (pt)
BR (1) BR9508760A (pt)
CA (1) CA2156768A1 (pt)
CZ (1) CZ287558B6 (pt)
DE (1) DE69528838T2 (pt)
DK (1) DK0777477T3 (pt)
ES (1) ES2187566T3 (pt)
HU (1) HU227759B1 (pt)
MX (1) MX9701390A (pt)
NO (1) NO322200B1 (pt)
NZ (1) NZ291223A (pt)
PL (1) PL181215B1 (pt)
PT (1) PT777477E (pt)
RU (1) RU2140782C1 (pt)
SK (1) SK282183B6 (pt)
TW (1) TW493984B (pt)
UA (1) UA42781C2 (pt)
WO (1) WO1996005834A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
US7183410B2 (en) 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
PL1912650T3 (pl) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
ZA200803566B (en) * 2005-12-12 2009-10-28 Adcock Ingram Ltd Pharmaceutical compositions
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
EP2039359A4 (en) 2006-07-12 2009-11-25 Aska Pharm Co Ltd ANALGICAL AGENT
CA2660476C (en) 2006-08-14 2015-11-17 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
KR20090045945A (ko) 2006-08-25 2009-05-08 베링거 인겔하임 인터내셔날 게엠베하 제어 방출 시스템 및 이의 제조방법
KR20090065513A (ko) * 2006-10-05 2009-06-22 코와 가부시키가이샤 이부프로펜 및 트라넥삼산을 함유하는 고형 제제
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
PT2279731E (pt) * 2008-04-23 2013-08-30 Farmasierra Mfg S L Composição farmacêutica melhorada contendo ibuprofeno e codeína
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
KR101317809B1 (ko) 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
JP6664395B2 (ja) 2014-08-28 2020-03-13 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 急性疼痛治療用フィルムコーティング錠剤
CN105395508B (zh) * 2015-12-14 2018-06-29 西南药业股份有限公司 一种洛芬待因复方制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
GB8905815D0 (en) * 1989-03-14 1989-04-26 Beecham Group Plc Medicament
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament

Also Published As

Publication number Publication date
KR100397082B1 (ko) 2004-02-11
HUT77385A (hu) 1998-04-28
PL181215B1 (pl) 2001-06-29
UA42781C2 (uk) 2001-11-15
CN1083265C (zh) 2002-04-24
DE69528838T2 (de) 2003-07-10
SK282183B6 (sk) 2001-11-06
PL318807A1 (en) 1997-07-07
NZ291223A (en) 1998-12-23
MX9701390A (es) 1998-06-30
CN1159754A (zh) 1997-09-17
EP0777477A1 (en) 1997-06-11
NO970782L (no) 1997-02-20
HU227759B1 (en) 2012-02-28
JPH10504557A (ja) 1998-05-06
DE69528838D1 (de) 2002-12-19
RU2140782C1 (ru) 1999-11-10
AU3228995A (en) 1996-03-14
SK23697A3 (en) 1997-08-06
AU699224B2 (en) 1998-11-26
KR970705389A (ko) 1997-10-09
ES2187566T3 (es) 2003-06-16
PT777477E (pt) 2003-03-31
CA2156768A1 (en) 1996-02-24
CZ287558B6 (en) 2000-12-13
CZ54697A3 (en) 1997-12-17
BG101252A (en) 1998-02-27
NO970782D0 (no) 1997-02-20
ATE227574T1 (de) 2002-11-15
JP3874793B2 (ja) 2007-01-31
WO1996005834A1 (en) 1996-02-29
BG63329B1 (bg) 2001-10-31
DK0777477T3 (da) 2003-03-17
BR9508760A (pt) 1998-01-13
TW493984B (en) 2002-07-11
EP0777477B1 (en) 2002-11-13

Similar Documents

Publication Publication Date Title
NO322200B1 (no) Forbedrede farmasoytiske preparater inneholdende ibuprofen og kodein og fremgangsmate for fremstilling derav
TW506836B (en) Fast-dissolving galanthamine hydrobromide tablet
AU2006248593B2 (en) Dispersible bosertan tablet
WO1995022974A2 (en) Film coated tablet of paracetamol and domperidone
NZ270748A (en) Sustained release dosage form of alfuzosin hydrochloride coated with a ph-dissolution dependent polymer
US4888343A (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
US7993673B2 (en) Swallow tablet comprising paracetamol
AU2002317772A1 (en) Swallow tablet comprising paracetamol
JPH05246845A (ja) イブプロフェン含有解熱鎮痛剤
EP0975337B1 (en) Fast release compressed tablet of flurbiprofen
JP4824224B2 (ja) 糖衣製剤
TWI589292B (zh) 用於控管噁心及嘔吐之組合物
KR20030070594A (ko) 암로디핀 말레에이트를 포함하는 약학 조성물
JP2010037224A (ja) エテンザミドの昇華が抑制された固形製剤
HK1062896B (en) Swallow tablet comprising paracetamol
HK136097A (en) Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as active ingredient

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees